RECRUITING

Effect of Electro-Acupuncture on Blood Pressure

Talk to us

Conditions

Hypertensionblood pressuremild to moderate hypertension

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Based on previous published research in animals and human, the investigators hypothesize that electroacupuncture (EA) will have a positive effect on hypertension.

Official Title

Neural Mechanism of the Effect of Acupuncture on Hypertension

Quick Facts

Study Start:2003-02
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT00932139

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:39 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients with mild coronary disease, and no significant ECG change reflecting ischemia at rest.
  2. * Patients with high blood pressure with or without antihypertensive medication.
  1. * Pregnant or nursing women
  2. * Individuals with severe coronary disease (continuous angina)
  3. * Conduction abnormalities on ECG consistent with left bundle branch block
  4. * Cardiac arrhythmias associated with low blood pressure (90 mmHg)
  5. * Peripheral vascular disease
  6. * Orthopedic disease
  7. * Diabetic or psychological illness that could interfere with safe performance of exercise of psychophysiological stress testing
  8. * Those with known sensitivity to topical preparations or strong reactions to medical dressings and skin tapes

Contacts and Locations

Study Contact

Stephanie Tjen-A-Looi, PhD
CONTACT
stjenalo@uci.edu
Shaista Malik, MD, PhD, MPH
CONTACT
smalik@uci.edu

Principal Investigator

Stephanie Tjen-A-Looi, PhD
PRINCIPAL_INVESTIGATOR
University of California, Irvine
Liang-Wu Fu, MD, PhD
PRINCIPAL_INVESTIGATOR
University of California, Irvine
Shaista Malik, MD, PhD, MPH
PRINCIPAL_INVESTIGATOR
University of California, Irvine
LiFang Xie, PhD, LAc
PRINCIPAL_INVESTIGATOR
University of California, Irvine

Study Locations (Sites)

Susan Samueli Integrative Health Institute
Costa Mesa, California, 92626
United States
UCIMedical Center
Orange, California, 92868
United States

Collaborators and Investigators

Sponsor: University of California, Irvine

  • Stephanie Tjen-A-Looi, PhD, PRINCIPAL_INVESTIGATOR, University of California, Irvine
  • Liang-Wu Fu, MD, PhD, PRINCIPAL_INVESTIGATOR, University of California, Irvine
  • Shaista Malik, MD, PhD, MPH, PRINCIPAL_INVESTIGATOR, University of California, Irvine
  • LiFang Xie, PhD, LAc, PRINCIPAL_INVESTIGATOR, University of California, Irvine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2003-02
Study Completion Date2027-12

Study Record Updates

Study Start Date2003-02
Study Completion Date2027-12

Terms related to this study

Keywords Provided by Researchers

  • Hypertension
  • blood pressure
  • mild to moderate hypertension

Additional Relevant MeSH Terms

  • Hypertension